These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 34142412)

  • 1. Blood glucose monitoring by insulin-treated pilots of commercial and private aircraft: An analysis of out-of-range values.
    Garden GL; Frier BM; Hine JL; Hutchison EJ; Mitchell SJ; Shaw KM; Heller SR; Koehler G; Hofmann V; Gaffney TP; Maher D; Roberts GA; Russell-Jones DL
    Diabetes Obes Metab; 2021 Oct; 23(10):2303-2310. PubMed ID: 34142412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of the Safety of Pilots With Insulin-Treated Diabetes in Europe Flying Commercial and Noncommercial Aircraft.
    Garden GL; Hine JL; Mitchell SJ; Hutchison EJ; Gaffney TP; Hofmann V; Frier BM; Shaw KM; Heller SR; Koehler G; Roberts GA; Russell-Jones DL
    Diabetes Care; 2020 Dec; 43(12):2923-2929. PubMed ID: 32586987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study.
    Garden GL; Shojaee-Moradie F; Hutchison EJ; Frier BM; Shaw KM; Heller SR; Koehler G; Mader JK; Maher D; Roberts GA; Russell-Jones DL
    Diabetes Technol Ther; 2023 Aug; 25(8):543-548. PubMed ID: 37384853
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous Glucose Monitoring for In-Flight Measurement of Glucose Levels of Insulin-Treated Pilots.
    Strollo F; Simons R; Mambro A; Strollo G; Gentile S
    Aerosp Med Hum Perform; 2019 Aug; 90(8):735-737. PubMed ID: 31331425
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical Certification of Pilots Through the Insulin-Treated Diabetes Mellitus Protocol at the FAA.
    Stanwyck LK; DeVoll JR; Pastore J; Gamble Z; Poe A; Gui GV
    Aerosp Med Hum Perform; 2022 Aug; 93(8):627-632. PubMed ID: 36050848
    [No Abstract]   [Full Text] [Related]  

  • 6. GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
    Aberer F; Lichtenegger KM; Smajic E; Donsa K; Malle O; Samonigg J; Höll B; Beck P; Pieber TR; Plank J; Mader JK
    Diabetes Obes Metab; 2019 Mar; 21(3):584-591. PubMed ID: 30328252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
    Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
    Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P; Davies C; Emery CJ; Heller SR
    Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The U.S. Experience with Waivers for Insulin-Treated Pilots.
    Mills WD; DeJohn CA; Alaziz M
    Aerosp Med Hum Perform; 2017 Jan; 88(1):34-41. PubMed ID: 28061920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy.
    Ringholm L; Roskjær AB; Engberg S; Andersen HU; Secher AL; Damm P; Mathiesen ER
    Diabetologia; 2019 Mar; 62(3):387-398. PubMed ID: 30607466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
    Christensen MB; Gæde P; Hommel E; Gotfredsen A; Nørgaard K
    Diabetes Metab; 2020 Feb; 46(1):61-65. PubMed ID: 30796973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.
    Gómez AM; Imitola Madero A; Henao Carrillo DC; Rondón M; Muñoz OM; Robledo MA; Rebolledo M; García Jaramillo M; León Vargas F; Umpierrez G
    J Diabetes Sci Technol; 2020 Mar; 14(2):233-239. PubMed ID: 30678495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering of glucose in critical care: a randomized pilot trial.
    McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
    J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.